Segui
james shaw
james shaw
Email verificata su ncl.ac.uk - Home page
Titolo
Citata da
Citata da
Anno
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ...
The Lancet 368 (9541), 1096-1105, 2006
22222006
Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding …
M Marre, J Shaw, M Brändle, WMW Bebakar, NA Kamaruddin, J Strand, ...
Diabetic Medicine 26 (3), 268-278, 2009
11492009
Pancreas transplantation
SA White, JA Shaw, DER Sutherland
The Lancet 373 (9677), 1808-1817, 2009
4142009
Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes
S Colagiuri, CMY Lee, TY Wong, B Balkau, JE Shaw, K Borch-Johnsen, ...
Diabetes care 34 (1), 145-150, 2011
3732011
Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2× 2 factorial randomized controlled trial comparing insulin pump with multiple daily …
SA Little, L Leelarathna, E Walkinshaw, HK Tan, O Chapple, ...
Diabetes care 37 (8), 2114-2122, 2014
2482014
Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk
P Choudhary, J Shin, Y Wang, ML Evans, PJ Hammond, D Kerr, ...
Diabetes care 34 (9), 2023-2025, 2011
2282011
Circulating endothelial progenitor cells, endothelial function, carotid intima–media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes …
L Sibal, A Aldibbiat, SC Agarwal, G Mitchell, C Oates, S Razvi, JU Weaver, ...
Diabetologia 52, 1464-1473, 2009
1752009
Type 2 diabetes: the pathologic basis of reversible β-cell dysfunction
MG White, JAM Shaw, R Taylor
Diabetes care 39 (11), 2080-2088, 2016
1722016
Defining outcomes for β‐cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop
MR Rickels, PG Stock, EJP De Koning, L Piemonti, J Pratschke, ...
Transplant international 31 (4), 343-352, 2018
1712018
Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial
MD Campbell, M Walker, RM Bracken, D Turner, EJ Stevenson, ...
BMJ Open Diabetes Research and Care 3 (1), e000085, 2015
1432015
Evaluation of a quality‐of‐life tool for cats with diabetes mellitus
SJM Niessen, S Powney, J Guitian, APM Niessen, PD Pion, JAM Shaw, ...
Journal of Veterinary Internal Medicine 24 (5), 1098-1105, 2010
1332010
Glucagon-like peptide 1 protects pancreatic β-cells from death by increasing autophagic flux and restoring lysosomal function
FP Zummo, KS Cullen, M Honkanen-Scott, JAM Shaw, PE Lovat, C Arden
Diabetes 66 (5), 1272-1285, 2017
1152017
Expression of mesenchymal and α-cell phenotypic markers in islet β-cells in recently diagnosed diabetes
MG White, HL Marshall, R Rigby, GC Huang, A Amer, T Booth, S White, ...
Diabetes care 36 (11), 3818-3820, 2013
1142013
Insulin pumps
J Pickup
Diabetes technology & therapeutics 16 (S1), S-17-S-22, 2014
1102014
Recommendations for health equity and virtual care arising from the COVID-19 pandemic: narrative review
J Shaw, LPC Brewer, T Veinot
JMIR Formative Research 5 (4), e23233, 2021
1032021
The relationship of retinal vascular calibre to diabetes and retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study
G Tikellis, JJ Wang, R Tapp, R Simpson, P Mitchell, PZ Zimmet, J Shaw, ...
Diabetologia 50, 2263-2271, 2007
942007
2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial
A Al-Mrabeh, KG Hollingsworth, JAM Shaw, A McConnachie, N Sattar, ...
The lancet Diabetes & endocrinology 8 (12), 939-948, 2020
922020
Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2)
AD Barlow, J Xie, CE Moore, SC Campbell, JAM Shaw, ML Nicholson, ...
Diabetologia 55, 1355-1365, 2012
912012
Evaluation of a quality‐of‐life tool for dogs with diabetes mellitus
SJM Niessen, S Powney, J Guitian, APM Niessen, PD Pion, JAM Shaw, ...
Journal of Veterinary Internal Medicine 26 (4), 953-961, 2012
902012
Sustained reduction in severe hypoglycemia in adults with type 1 diabetes complicated by impaired awareness of hypoglycemia: two-year follow-up in the HypoCOMPaSS randomized …
SA Little, J Speight, L Leelarathna, E Walkinshaw, HK Tan, A Bowes, ...
Diabetes Care 41 (8), 1600-1607, 2018
802018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20